Nuclear medicine applications in molecular imaging: 2007 update.
This review examines several classes of radiolabeled agents, including analogs localizing in somatostatin, benzodiazepine and dopamine receptors; analogs of progesterone and estrogen; and agents localizing in lesions with hypoxia. It concludes the status of agents advocated for detecting angiogenesis and inflammation. The current clinical status of these agents, and their potential roles in diagnosis and treatment are discussed.
Blankenberg
F G
FG
Division of Pediatric Radiology, F.G.B.-Department of Radiology, Lucile Salter Packard Children's Hospital, Stanford, CA, USA. blankenb@stanford.edu
Strauss
H W
HW
D000818:Animals; D016503:Drug Delivery Systems / Q000639:trends*; D005544:Forecasting; D006801:Humans; D015336:Molecular Probe Techniques / Q000639:trends*; D009683:Nuclear Medicine / Q000639:trends*; D049268:Positron-Emission Tomography / Q000639:trends*; D015899:Tomography, Emission-Computed, Single-Photon / Q000639:trends*